Sign in

CIK 0000748592 · Non-accelerated filer<br>Smaller reporting company

Ernexa Therapeutics Inc.

Sign in to watch
Ticker
ERNA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
311103425
Phone
(617) 798-6700
Business address
1035 CAMBRIDGE STREET, SUITE 18A, CAMBRIDGE, MA, 02141
Former names
Eterna Therapeutics Inc., Brooklyn ImmunoTherapeutics, Inc., NTN BUZZTIME INC, NTN COMMUNICATIONS INC

Securities

  • ERNA Common Stock Nasdaq
  • ERNAW Warrants Nasdaq
  1. 8-K Event Item 5 · Item 7
  2. S-3/A Offering Registration Statement
  3. 10-K/A Report 10-K/A
  4. S-3/A Offering Registration Statement
  5. S-3 Offering Registration Statement
  6. 10-K Report Annual Report
  7. SC 13G/A Stake Amended Statement of Ownership
  8. DEFS14A Other DEFS14A
  9. SC 13G Stake Amended Statement of Ownership
  10. PRES14A Other PRES14A
  11. 10-Q Report Quarterly Report
  12. 10-Q Report Quarterly Report
  13. SC 13G Stake Amended Statement of Ownership
  14. DEF 14A Proxy Proxy Statement
  15. S-3/A Offering Registration Statement
  16. S-3 Offering Registration Statement
  17. 10-Q Report Quarterly Report
  18. 10-K Report Annual Report
  19. 424B3 Offering Prospectus
  20. S-3 Offering Registration Statement

Page 73 of 77 · 1,525 filings